Written answers
Tuesday, 20 March 2018
Department of Health
Vaccination Programme Data
Michael Healy-Rae (Kerry, Independent)
Link to this: Individually | In context | Oireachtas source
520. To ask the Minister for Health the recorded cases of vasculitis following HPV immunisation (details supplied); and if he will make a statement on the matter. [12243/18]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The information that the Deputy seeks with regard to recorded cases of vasculitis following HPV immunisation is not readily available. Therefore, I have asked the Health Products Regulatory Authority (HPRA) to investigate the matter and reply directly to the Deputy.
It is important to reiterate that the HPRA and the European Medicines Agency continually monitor adverse events to vaccination. HPV is one of the most closely studied and monitored medicinal products. The vast majority of reports received by the HPRA have been consistent with the expected pattern of short term adverse side effects for the vaccine, as described in the product information. Mild and temporary reactions to any kind of vaccination are not unusual.
No comments